amino retatrutide 💠 (Reta) is a synthetic peptide-based drug composed of 39 acids. It was developed by Eli Lilly and is being studied extensively as a treatment for obesity and metabolic diseases Reta (RUO) | GIP/GLP-1/GCG Agonist

Some key side effects and risks to be aware of with GLP-1s Using care with prescription weight-loss medications is a critical piece of a responsible modern weight-care program

Check the expiry date and confirm the correct dose as instructed by your clinical team

The PSPeptides Advantage: Quality, Speed, and Trust PSPeptides combines every advantage researchers need in a single vendor

The peptide is typically supplied as a lyophilized powder (e.g., 5 mg, 10 mg, 20 mg per vial) that must be reconstituted with bacteriostatic water before injection

Consistent with the known effects and common side effects of semaglutide, more participants receiving active medication reported decreased appetite as well as increased nausea and constipation

Patients currently on semaglutide who have hit a weight loss plateau often see renewed progress when transitioning to tirzepatide, likely due to the additional GIP receptor activation